Non-coding RNAs in hypertrophic scars and keloids: Current research and clinical relevance: A review

被引:10
作者
Su, Linlin [1 ]
Han, Juntao [1 ,2 ]
机构
[1] Air Force Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shaanxi, Peoples R China
[2] 127 Changle West Rd, Xian 710032, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Hypertrophic scar; Keloid; miRNAs; lncRNAs; circRNAs; EXPRESSION PROFILES; TGF-BETA/SMAD; FIBROBLASTS; PROLIFERATION; GROWTH; PROGRESSION; MIGRATION; APOPTOSIS; PROMOTES; PROTEINS;
D O I
10.1016/j.ijbiomac.2023.128334
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypertrophic scars (HS) and keloids (KD) are lesions that develop as a result of excessive fibroblast proliferation and collagen deposition in response to dermal injury, leading to dysregulation of the inflammatory, proliferative, and remodeling phases during wound healing. HS and KD affect up to 90 % of the population and are associated with lower quality of life, physical health, and mental status in patients. Efficient targeted treatment represents a significant challenge, primarily due to our limited understanding of their underlying pathogenesis. Non-coding RNAs (ncRNAs), which constitute a significant portion of the human transcriptome with minimal or no proteincoding capacity, have been implicated in various cellular physiologies and pathologies and may serve as diagnostic indicators or therapeutic targets. NcRNAs have been found to be aberrantly expressed and regulated in HS and KD. This review provides a summary of the expression profiles and molecular mechanisms of three common ncRNAs, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), in HS and KD. It also discusses their potential as biomarkers for the diagnosis and treatment of these diseases and provides novel insights into epigenetic-based diagnosis and treatment strategies for HS and KD.
引用
收藏
页数:12
相关论文
共 168 条
[11]   Circ_0008450 downregulates Runx3 to promote the proliferation and epithelial-mesenchymal transition of human keratinized epithelial cells [J].
Chen, Huaxia ;
Xu, Xiao ;
Lai, Linying ;
Huo, Ran ;
Chen, Minliang .
CELL CYCLE, 2020, 19 (23) :3303-3316
[12]   Blockade of lncRNA-ASLNCS5088-enriched exosome generation in M2 macrophages by GW4869 dampens the effect of M2 macrophages on orchestrating fibroblast activation [J].
Chen, Jialin ;
Zhou, Renpeng ;
Liang, Yimin ;
Fu, Xiujun ;
Wang, Danru ;
Wang, Chen .
FASEB JOURNAL, 2019, 33 (11) :12200-12212
[13]   Exosome from adipose-derived mesenchymal stem cells attenuates scar formation through microRNA-181a/SIRT1 axis [J].
Chen, Jie ;
Yu, Wenjuan ;
Xiao, Chao ;
Su, Na ;
Han, Yubo ;
Zhai, Liang ;
Hou, Chen .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2023, 746
[14]   Overexpression of LncRNA AC067945.2 Down-Regulates Collagen Expression in Skin Fibroblasts and Possibly Correlates with the VEGF and Wnt Signalling Pathways [J].
Chen, Ling ;
Li, Jingyun ;
Li, Qian ;
Li, Xue ;
Gao, Yanli ;
Hua, Xiangdong ;
Zhou, Bei ;
Li, Jun .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 45 (02) :761-771
[15]   Non-Coding RNAs: The New Insight on Hypertrophic Scar [J].
Chen, Ling ;
Li, Jingyun ;
Li, Qian ;
Yan, Hui ;
Zhou, Bei ;
Gao, Yanli ;
Li, Jun .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (08) :1965-1968
[16]   Detection and analysis of long noncoding RNA expression profiles related to epithelial-mesenchymal transition in keloids [J].
Chen, Zhixiong ;
Chu, Xi ;
Xu, Jinghong .
BIOMEDICAL ENGINEERING ONLINE, 2022, 21 (01)
[17]   Biogenesis, Functions, and Role of CircRNAs in Lung Cancer [J].
Dong, Huanhuan ;
Zhou, Junliang ;
Cheng, Yue ;
Wang, Meiqi ;
Wang, Shuqing ;
Xu, Hui .
CANCER MANAGEMENT AND RESEARCH, 2021, 13 :6651-6671
[18]   Identification and analysis of dysregulated lncRNA and associated ceRNA in the pathogenesis of keloid [J].
Duan, Xilei ;
Wu, Yuemeng ;
Zhang, Zheng ;
Lu, Zhong .
ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (05)
[19]  
EHRLICH HP, 1994, AM J PATHOL, V145, P105
[20]  
El Kinani M., 2020, Textbook on Scar Management: State of the Art Management and Emerging Technologies [Internet], V6